title: Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
abstract: BACKGROUND
  The disturbances of haemostasis and enhanced oxidative stress (SOX) appear to contribute to the cardiovascular disease (CVD) in hemodialysis (HD) patients. The aim of the present study was to investigate if the disorders of coagulation/fibrinolysis system are associated with the presence of CVD in these patients.
  
  
  METHODS
  We compared pre-dialysis levels of uPA, suPAR, tissue factor (TF) and its inhibitor (TFPI), prothrombin fragment F1+2 (F1+2); a marker of SOX-Cu/Zn superoxide dismutase (Cu/Zn SOD) and a surrogate of inflammation-high sensitivity C-reactive protein (hs CRP) in HD patients with and without CVD.
  
  
  RESULTS
  The uPA/suPAR system and hs CRP values were significantly greater in patients with CVD than in those without CVD; whereas TF, TFPI, F1+2 and Cu/Zn SOD levels were comparable in both patient groups. TF was positively correlated with both uPA (p<0.001) and suPAR levels (p<0.05). Logistic regression analysis showed that elevated levels of suPAR, TF and uPA were independently associated with the presence of CVD in HD patients.
  
  
  CONCLUSIONS
  The association between TF and uPA/suPAR system is significantly related to the presence of CVD in HD patients.
authors.affiliation: Department of Nephrology and Clinical Transplantation, Medical University, 14 Zurawia St, 15-540, Bialystok, Poland. krystynapawlak@poczta.onet.pl
authors.forename: Krystyna
authors.initials: K
authors.lastname: Pawlak
authors.forename: Dariusz
authors.initials: D
authors.lastname: Pawlak
authors.forename: Michal
authors.initials: M
authors.lastname: Mysliwiec
mesh_terms: D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000097:blood* / Q000150:complications*; D005260:Female; D005342:Fibrinolysis; D006487:Hemostasis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000150:complications* / Q000628:therapy; D008074:Lipoproteins / Q000097:blood; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress; D010446:Peptide Fragments / Q000097:blood; D011516:Prothrombin; D006435:Renal Dialysis; D013482:Superoxide Dismutase / Q000378:metabolism; D013925:Thromboplastin / Q000378:metabolism*; D014568:Urokinase-Type Plasminogen Activator / Q000097:blood*
chemical_list: D015415:Biomarkers; D008074:Lipoproteins; D010446:Peptide Fragments; C051928:lipoprotein-associated coagulation inhibitor; C045879:prothrombin fragment 1.2; D011516:Prothrombin; D002097:C-Reactive Protein; D013925:Thromboplastin; D013482:Superoxide Dismutase; D014568:Urokinase-Type Plasminogen Activator